Gritstone Bio Inc (NAS:GRTS)
$ 0.8179 0.0305 (3.87%) Market Cap: 88.80 Mil Enterprise Value: 142.47 Mil PE Ratio: 0 PB Ratio: 5.84 GF Score: 30/100

Gritstone Oncology Inc Corporate Investor Event at Society for Immunotherapy of Cancer (SITC) Conference Transcript

Nov 08, 2019 / 11:00PM GMT
Release Date Price: $7.8 (-1.39%)
Andrew R. Allen
Gritstone Oncology, Inc. - Co-Founder, President, CEO & Director

We're good? Okay. Good evening, everybody. Thank you for joining us. This is the Gritstone Oncology webcast investor presentation coming to you live from the Society of the Immunotherapy of Cancer Meeting in National Harbor, Maryland. It's November 8, and it is about 10 after 6 Eastern Time.

So this is a webcast, which means if you would like to ask a question, which we encourage and appreciate, we would ask that you signal and we will give you a microphone so that your question can be heard by those listening into the webcast. If you don't do that, then we simply have to repeat your question in a much less eloquent and compelling fashion than the manner in which I'm sure you will have asked it. And so please wait for the microphone.

So my name is Andrew Allen. I am the CEO, President and one of the co-founders of Gritstone Oncology. And this evening, we will be making some forward-looking statements. So I showed the appropriate warning on Slide 2.

And on Slide 3, we have the agenda for this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot